Microbes versus microbes: Immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens

FEMS Immunology and Medical Microbiology

Volumn 34, Issue 4, 2002, Pages 245-253

  Cross, Martin L ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

Bacterial pathogens; Immune modulation; Lactic acid bacteria; Lactobacillus; Probiotics; Protection

Indexed keywords

BACTERIAL IMMUNITY; CORRELATION ANALYSIS; HUMAN; IMMUNOMODULATION; LACTOBACILLUS; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0037073572     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(02)00377-2     Document Type: Article

References (62)

1. Metchnikoff, E. (1908) Prolongation of Life: Optimistic Studies. Putnam's Sons, New York.
2. Sudo N., Sawamura S., Tanaka K., Aiba Y., Kubo C., Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159:1997;1739-1745.
3. Kirjavainen P.V., Apostolou E., Arvola T., Salminen S.J., Gibson G.R., Isolauri E. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol. Med. Microbiol. 32:2001;1-7.
4. Kalliomaki M., Kirjavainen P., Eerola E., Kero P., Salminen S., Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107:2001;129-134.
5. Kalliomaki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 357:2001;1076-1079.
6. Kraehenbuhl J.P., Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2:2001;361-367.
7. Cleveland M.G., Gorham J.D., Murphy T.L., Tuomanen E., Murphy K.M. Lipoteichoic acid preparations of Gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect. Immun. 64:1996;1906-1912.
8. Yoshimura A., Lien E., Ingalls R.R., Tuomanen E., Dziarski R., Golenbock D. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1999;1-5.
9. Miettinen M., Lehtonen A., Julkunen I., Matikainen S. Lactobacilli and streptococci activate NF-κB and STAT signaling pathways in human macrophages. J. Immunol. 164:2000;3733-3740.
10. Miettinen M., Vuopio-Varkila J., Varkila K. Production of human tumour necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 64:1996;5403-5405.
11. Miettinen M., Matikeinen S., Vuopio-Varkila J., Pirhonen J., Varkila K., Kurimoto M., Julkunen I. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18 and gamma-interferon production in human peripheral blood mononuclear cells. Infect. Immun. 66:1999;6058-6062.
12. von der Weid T., Bulliard C., Schiffrin E.J. Induction by a lactic acid bacterium of a population of CD4+ T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin. Diagn. Lab. Immunol. 8:2001;695-701.
13. Christensen H.R., Frokiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168:2002;171-178.
14. Berg R.D. Bacterial translocation from the gastrointestinal tract. Trends Microbiol. 3:1995;149-154.
15. Perdigon G., Vintini E., Alvarez S., Medina M., Medici M. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J. Dairy Sci. 82:1999;1108-1114.
16. Perdigon G., Rachid M., De Budeguer M.V., Valdez J.C. Effect of yogurt feeding on the small and large intestine associated lymphoid cells in mice. J. Dairy Res. 61:1994;553-562.
17. Herias M.V., Hessle C., Telemo E., Midtvedt T., Hanson L.A., Wold A.E. Immunomodulatory effects of Lactobacillus plantarum colonizing the intestine of gnotobiotic rats. Clin. Exp. Immunol. 116:1999;283-290.
18. Yasui H., Nagaoka N., Mike A., Hayakawa K., Ohwaki M. Detection of Bifidobacterium strains that induce large quantities of IgA. Microb. Ecol. Health Dis. 5:1992;155-162.
19. Vitini E., Alvarez S., Medina M., Medici M., de Budeguer M.V., Perdigon G. Gut mucosal immunostimulation by lactic acid bacteria. Biocell. 24:2000;223-232.
20. Kato I., Tanaka K., Yokokura T. Lactic acid bacterium potently induces the production of interleukin-12 and interferon-γ by mouse splenocytes. Int. J. Immunopharmacol. 21:1999;121-131.
21. Nagao F., Nakayama M., Muto T., Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci. Biotechnol. Biochem. 64:2000;2706-2708.
22. Aso Y., Akaza H., Kotake T. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. Eur. Urol. 27:1995;104-109.
23. Takagi A., Matsuzaki T., Sato M., Nomoto K., Morotomi M., Yokokura T. Inhibitory effect of oral administration of Lactobacillus casei on 3 methylcholanthrene-induced carcinogenesis in mice. Med. Microbiol. Immunol. 188:1999;111-116.
24. Majamaa H., Isolauri E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 99:1997;179-185.
25. Madsen K.L., Doyle J.S., Jewell L.D., Tavernini M.M., Fedorak R.N. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology. 116:1999;1107-1114.
26. Matsumoto S., Watanabe N., Imaoka A., Okabe Y. Preventive effects of Bifidobacterium- and Lactobacillus-fermented milk on the development of inflammatory bowel disease in senescence-accelerated mouse P1/Yit strain mice. Digestion. 64:2001;92-99.
27. Maassen C.B., van Holten-Neelen C., Balk F., den Bak-Glashouwer M.J., Leer R.J., Laman J.D., Boersma W.J., Claassen E. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine. 18:2000;2613-2623.
28. Elmer G.W., Surawicz C.M., McFarland L.V. Biotherapeutic agents: a neglected modality for the prevention and treatment of selected intestinal and vaginal infections. JAMA. 272:1996;870-876.
29. Reid G., Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microb. Infect. 4:2002;319-324.
30. Alvarez-Olmos M.I., Oberhelman R.A. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin. Infect. Dis. 32:2001;1567-1575.
31. Perdigon G., de Marcias M.E.N., Alvarez S., Oliver G., de Ruiz Holgado A.P. Prevention of gastrointestinal infection using immunobiological methods with milk fermented with Lactobacillus casei and Lactobacillus acidophilus. J. Dairy Res. 57:1990;255-264.
32. Paubert-Braquet M., Gan X.H., Gaudichon C., Hedef N., Serikoff A., Bouley C., Bonavida B., Braquet P. Enhancement of host resistance against Salmonella typhimurium in mice fed a diet supplemented with yogurt or milks fermented with various Lactobacillus casei strains. Int. J. Immunother. 11:1995;153-161.
33. Gill H.S., Shu Q., Lin H., Rutherfurd K.J., Cross M.L. Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001. Med. Microbiol. Immunol. 190:2001;97-104.
34. Shu Q., Rutherfurd K.J., Fenwick S.G., Prasad J., Gopal P.K., Gill H.S. Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice. Microbiol. Immunol. 44:2000;213-222.
35. Perdigon G., Alvarez S., de Ruiz Holgado A.P. Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections. J. Dairy Res. 58:1991;485-496.
36. Perdigon G., Alvarez S., Nader de Macias M.E., Roux M.E., de Ruiz Holgado A.P. The oral administration of lactic acid bacteria increases the mucosal immunity in response to enteropathogens. J. Food Protect. 53:1990;404-410.
37. Nader de Macias M.E., Apella M.C., Romero N.C., Gonzalez S.N., Oliver G. Inhibition of Shigella sonnei by Lactobacillus casei and Lact. acidophilus. J. Appl. Bacteriol. 73:1992;407-411.
38. de Waard R., Garssen J., Bokken G.C., Vos J.G. Antagonistic activity of Lactobacillus casei strain Shirota against gastrointestinal Listeria monocytogenes infection in rats. Int. J. Food Microbiol. 73:2002;93-100.
39. Yasui H., Kiyoshima J., Ushijima H. Passive protection against rotavirus-induced diarrhea of mouse pups born to and nursed by dams fed Bifidobacterium breve YIT4064. J. Infect. Dis. 172:1995;403-409.
40. Qiao H., Duffy L.C., Griffiths E., Dryja D., Leavens A., Rossman J., Rich G., Riepenhoff-Talty M., Locniskar M. Immune responses in rhesus rotavirus-challenged BALB/c mice treated with bifidobacteria and prebiotic supplements. Pediatr. Res. 51:2002;750-755.
41. Shu Q., Qu F., Gill H.S. Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. J. Pediatr. Gastroenterol. Nutr. 33:2001;171-177.
42. Shu Q., Gill H.S. A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice. Med. Microbiol. Immunol. 189:2001;147-152.
43. Ogawa M., Shimizu K., Nomoto K., Takahashi M., Watanuki M., Tanaka R., Tanaka T., Hamabata T., Yamasaki S., Takeda Y. Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits. Infect. Immun. 69:2001;1101-1108.
44. Kaila M., Isolauri E., Soppi E., Virtanen E., Laine S., Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr. Res. 32:1992;141-144.
45. Majamaa H., Isolauri E., Saxelin M., Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr. 20:1995;333-338.
46. Araki T., Shinozaki T., Irie Y., Miyazawa Y. Trial of oral administration of Bifidobacterium breve for the prevention of rotavirus infection. J. Jpn. Assoc. Infect. Dis. 73:1999;305-310.
47. Isolauri E., Joensuu J., Suomalainen H., Luomala M., Vesikari T. Improved immunogenicity of oral D×RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine. 13:1995;310-312.
48. Link-Amster H., Rochat F., Saudan K.Y., Mignot O., Aeschlimann J.M. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol. Med. Microbiol. 10:1994;55-63.
49. Fang H., Elina T., Heikki A., Seppo S. Modulation of humoral immune response through probiotic intake. FEMS Immunol. Med. Microbiol. 29:2000;47-52.
50. Alvarez S., Herrero C., Bru E., Perdigon G. Effect of Lactobacillus casei and yogurt administration on prevention of Pseudomonas aeruginosa infection in young mice. J. Food Prot. 64:2001;1768-1774.
51. Yasui H., Kiyoshima J., Hori T., Shida K. Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064. Clin. Diagn. Lab. Immunol. 6:1999;186-192.
52. Hori T., Kiyoshima J., Shida K., Yasui H. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin. Diagn. Lab. Immunol. 9:2002;105-108.
53. Hatakka K., Savilahti E., Ponka A., Meurman J.H., Poussa T., Nase L., Saxelin M., Korpela R. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ. 322:2001;1327-1331.
54. Bao S., Beagley K.W., France M.P., Shen J., Husband A.J. Interferon-gamma plays a critical role in intestinal immunity against Salmonella typhimurium infection. Immunol. 99:2000;464-472.
55. Alak J.I., Wolf B.W., Mdurvwa E.G., Pimentel-Smith G.E., Kolavala S., Abdelrahman H., Suppiramaniam V. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of Cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice. Cell Mol. Biol. 45:1999;855-863.
56. De Petrino S.F., de Jorrat M.E.B., Meson O., Perdigon G. Protective ability of certain lactic acid bacteria against an infection with Candida albicans in a mouse immunosuppression model by corticoid. Food Agric. Immunol. 7:1995;365-373.
57. Wagner R.D., Pierson C., Warner T., Dohnalek M., Farmer J., Roberts L., Hilty M., Balish E. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect. Immun. 65:1997;4165-4172.
58. Wagner R.D., Pierson C., Warner T., Dohnalek M., Hilty M., Balish E. Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice. J. Food Prot. 63:2000;638-644.
59. Cangemi de Gutierrez R., Santos V., Nader-Macias M.E. Protective effect of intranasally inoculated Lactobacillus fermentum against Streptococcus pneumoniae challenge on the mouse respiratory tract. FEMS Immunol. Med. Microbiol. 31:2001;187-195.
60. Reid G., Beuerman D., Heinemann C., Bruce A.W. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol. Med. Microbiol. 32:2001;37-41.
61. Gardiner G.E., Heinemann C., Bruce A.W., Beuerman D., Reid G. Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin. Diagn. Lab. Immunol. 9:2002;92-96.
62. Takahashi T., Kushiro A., Nomoto K., Uchida K., Morotomi M., Yokokura T., Akaza H. Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2. J. Urol. 2001;2506-2511.